甲状腺抗体共济失调的临床试验
总计2909个结果
-
AstraZeneca终止
-
Huazhong University of Science and TechnologyChinese PLA General Hospital; West China Hospital; Tongji Hospital; The First Affiliated Hospital... 和其他合作者未知
-
Mashhad University of Medical SciencesPharmaceutical Research Center未知
-
University of WashingtonNational Cancer Institute (NCI)完全的复发性甲状腺癌 | 甲状腺髓样癌 | IVA 期滤泡性甲状腺癌 | IVA 期甲状腺乳头状癌 | IVB 期滤泡性甲状腺癌 | IVB 期乳头状甲状腺癌 | IVC 期滤泡性甲状腺癌 | IVC 期甲状腺乳头状癌美国
-
National Cancer Institute (NCI)完全的难治性分化型甲状腺癌 | 不可切除的甲状腺癌 | 难治性甲状腺乳头状癌 | 难治性甲状腺滤泡癌 | 难治性甲状腺 Hurthle 细胞癌美国, 加拿大
-
Shanghai International Medical Center未知
-
Umraniye Education and Research Hospital未知甲状腺疾病 | 甲状腺肿瘤 | 甲状腺癌,乳头状 | 甲状腺癌 | 甲状腺结节 | 愿望 | 甲状腺肿大 | 甲状腺乳头状癌 | 多结节性甲状腺肿,青少年 | 孤立性甲状腺结节 | 多灶性发育不良火鸡
-
Seoul National University HospitalSMG-SNU Boramae Medical Center完全的
-
Rijnstate HospitalZonMw: The Netherlands Organisation for Health Research and Development; University of Twente; Amsterdam UMC招聘中
-
Memorial Sloan Kettering Cancer Center完全的甲状腺癌,乳头状 | 甲状腺癌,滤泡性 | 甲状腺癌 | 甲状腺癌 | 甲状腺癌(滤泡细胞) | BRAF V600E 突变阳性美国
-
Medstar Health Research InstitutePfizer完全的
-
Saint Petersburg State University, Russia撤销
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中低分化甲状腺癌 | 甲状腺鳞状细胞癌 | 不可切除的甲状腺癌 | 转移性甲状腺癌 | IVB 期甲状腺间变性癌 AJCC v8 | IVC 期甲状腺间变性癌 AJCC v8美国
-
Grupo Espanol de Tumores NeuroendocrinosGilead Sciences; MFAR尚未招聘
-
Memorial Sloan Kettering Cancer CenterAstraZeneca完全的
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
National Cancer Institute (NCI)完全的岛状甲状腺癌 | 复发性甲状腺癌 | II 期滤泡性甲状腺癌 | II 期乳头状甲状腺癌 | IV 期滤泡性甲状腺癌 | IV 期乳头状甲状腺癌美国
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘
-
Seno Medical Instruments Inc.终止Feasibility Study for Thyroid Indication美国
-
Children's Hospital of PhiladelphiaEli Lilly and Company; United States Department of Defense尚未招聘癌症 | 小儿癌症 | 分化型甲状腺癌 | 癌症, 甲状腺
-
Centre Francois BaclesseFondation avenir; laboratoire Genzyme完全的Thyroid Node | Indeterminate Cytology | Surgery Indication法国
-
National Cancer Institute (NCI)主动,不招人复发性甲状腺癌 | 难治性甲状腺癌 | III 期甲状腺滤泡性癌 AJCC v7 | IV 期甲状腺滤泡性癌 AJCC v7 | IV 期甲状腺乳头状癌 AJCC v7 | IVA 期甲状腺滤泡性癌 AJCC v7 | IVA 期甲状腺乳头状癌 AJCC v7 | IVB 期甲状腺滤泡性癌 AJCC v7 | IVB 期甲状腺乳头状癌 AJCC v7 | IVC 期甲状腺滤泡性癌 AJCC v7 | IVC 期甲状腺乳头状癌 AJCC v7 | 不可切除的甲状腺癌 | 分化型甲状腺癌 | III 期甲状腺髓样癌 AJCC v7 | IV 期甲状腺髓样癌 AJCC v7 | IVA 期甲状腺髓样癌 AJCC v7 | IVB 期甲状腺髓样癌 AJCC v7 | IVC 期甲状腺髓样癌... 及其他条件美国
-
Children's Hospital of PhiladelphiaBayer招聘中
-
Bhavana KondaNational Comprehensive Cancer Network主动,不招人
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)完全的
-
University of Alberta完全的
-
Meir Medical Center撤销
-
Azienda Ospedaliero, Universitaria PisanaMcGill University Health Centre/Research Institute of the McGill University Health Centre未知